ES2153789A1 - Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides - Google Patents

Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides

Info

Publication number
ES2153789A1
ES2153789A1 ES009901487A ES9901487A ES2153789A1 ES 2153789 A1 ES2153789 A1 ES 2153789A1 ES 009901487 A ES009901487 A ES 009901487A ES 9901487 A ES9901487 A ES 9901487A ES 2153789 A1 ES2153789 A1 ES 2153789A1
Authority
ES
Spain
Prior art keywords
aza
butylcarbamoyl
steroids
17beta
terc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009901487A
Other languages
English (en)
Other versions
ES2153789B1 (es
Inventor
Guisasola Luis Octavio Silva
Fernandez Cristina Blanco
Bonde-Larsen Antonio Lorente
Juarez Jorge Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Raga Consultores SL
Original Assignee
Raga Consultores SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009901487A priority Critical patent/ES2153789B1/es
Application filed by Raga Consultores SL filed Critical Raga Consultores SL
Priority to AT00940431T priority patent/ATE257842T1/de
Priority to HU0103002A priority patent/HUP0103002A3/hu
Priority to JP2001507858A priority patent/JP2003503507A/ja
Priority to DE60007716T priority patent/DE60007716T2/de
Priority to PCT/ES2000/000239 priority patent/WO2001002422A1/es
Priority to EP00940431A priority patent/EP1116725B1/en
Priority to CA002342864A priority patent/CA2342864A1/en
Publication of ES2153789A1 publication Critical patent/ES2153789A1/es
Priority to US09/800,019 priority patent/US6509466B2/en
Application granted granted Critical
Publication of ES2153789B1 publication Critical patent/ES2153789B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)

Abstract

Procedimiento de obtención de 17{be}-(n-terc-butilcarbamoil)-3- ona-4-aza-esteroides. Los 17{be}-(N-terc-butilcarbamoil)3-ona-4- aza-esteroides (I) pueden obtenerse mediante un procedimiento que comprende hacer reaccionar un 17{be}-(alcoxicarbonil)-3-ona-4- azaesteroide con un terc-butilamiduro de litio en un disolvente orgánico. Algunos compuestos de fórmula (I), por ejemplo, la finasterida, son útiles como inhibidores de la 5{al}-reductasa, y pueden ser utilizados en el tratamiento de la hiperplasia prostática benigna y la alopecia.
ES009901487A 1999-07-05 1999-07-05 Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides Expired - Fee Related ES2153789B1 (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ES009901487A ES2153789B1 (es) 1999-07-05 1999-07-05 Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides
HU0103002A HUP0103002A3 (en) 1999-07-05 2000-07-05 New process for obtaining 17betha-(n-terc-butylcarbamoyl)-3-one-4-aza-steroids
JP2001507858A JP2003503507A (ja) 1999-07-05 2000-07-05 17β(N−TERC−BUTYLCARBAMOYL)−3−ONE−4−AZA−STEROIDの製造方法
DE60007716T DE60007716T2 (de) 1999-07-05 2000-07-05 Verfahren zur gewinnung von 17beta-(n-tert-butylcarbamoyl)-3-on-4-aza-steroiden
AT00940431T ATE257842T1 (de) 1999-07-05 2000-07-05 Verfahren zur gewinnung von 17beta-(n-tert- butylcarbamoyl)-3-on-4-aza-steroiden
PCT/ES2000/000239 WO2001002422A1 (es) 1999-07-05 2000-07-05 PROCEDIMIENTO PARA LA OBTENCION DE 17β-(N-TERC-BUTILCARBAMOIL)-3-ONA-4-AZA-ESTEROIDES
EP00940431A EP1116725B1 (en) 1999-07-05 2000-07-05 Process for obtaining 17beta-(n-terc-butylcarbamoyl)-3-one-4-aza-steroids
CA002342864A CA2342864A1 (en) 1999-07-05 2000-07-05 Process for obtaining 17.beta.-(n-terc-butylcarbamoyl)-3-one-4-aza-steroids
US09/800,019 US6509466B2 (en) 1999-07-05 2001-03-05 Process for obtaining 17 β-(N-tert-butylcarbamoyl)-3-one-4-aza-steroids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009901487A ES2153789B1 (es) 1999-07-05 1999-07-05 Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides

Publications (2)

Publication Number Publication Date
ES2153789A1 true ES2153789A1 (es) 2001-03-01
ES2153789B1 ES2153789B1 (es) 2001-10-16

Family

ID=8309089

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009901487A Expired - Fee Related ES2153789B1 (es) 1999-07-05 1999-07-05 Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides

Country Status (9)

Country Link
US (1) US6509466B2 (es)
EP (1) EP1116725B1 (es)
JP (1) JP2003503507A (es)
AT (1) ATE257842T1 (es)
CA (1) CA2342864A1 (es)
DE (1) DE60007716T2 (es)
ES (1) ES2153789B1 (es)
HU (1) HUP0103002A3 (es)
WO (1) WO2001002422A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100415858B1 (ko) * 2001-09-22 2004-01-24 한미약품 주식회사 17베타-(엔-3차-부틸카바모일)-3-온 스테로이드 화합물의제조방법
US10351615B2 (en) 2006-02-03 2019-07-16 Opko Biologics Ltd. Methods of treatment with long-acting growth hormone
US9458444B2 (en) 2006-02-03 2016-10-04 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
FR3106058B1 (fr) * 2020-01-09 2022-01-07 Oreal Procédé de traitement cosmétique
CN114213502B (zh) * 2021-12-08 2024-02-13 湖南醇健制药科技有限公司 一种非那雄胺的精制方法及非那雄胺制剂和其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0367502A1 (en) * 1988-10-31 1990-05-09 Merck & Co. Inc. Methods of synthesizing benign prostatic hypertrophic agents
EP0599376A2 (en) * 1992-11-19 1994-06-01 Merck & Co. Inc. A process for the production of finasteride
WO1995000531A1 (en) * 1993-06-24 1995-01-05 Richter Gedeon Vegyészeti Gyár Rt. NOVEL PROCESS FOR PREPARING 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES
US5670643A (en) * 1995-03-16 1997-09-23 Glaxo Wellcome Inc. Method for preparing finasteride
GB2338234A (en) * 1998-06-10 1999-12-15 Torcan Chemical Ltd Finasteride preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760071A (en) 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0367502A1 (en) * 1988-10-31 1990-05-09 Merck & Co. Inc. Methods of synthesizing benign prostatic hypertrophic agents
EP0599376A2 (en) * 1992-11-19 1994-06-01 Merck & Co. Inc. A process for the production of finasteride
WO1995000531A1 (en) * 1993-06-24 1995-01-05 Richter Gedeon Vegyészeti Gyár Rt. NOVEL PROCESS FOR PREPARING 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES
US5670643A (en) * 1995-03-16 1997-09-23 Glaxo Wellcome Inc. Method for preparing finasteride
GB2338234A (en) * 1998-06-10 1999-12-15 Torcan Chemical Ltd Finasteride preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PENG XIA y col. Synthesis of N-Substituted 3-Oxo-17beta-Carboxamide-4-Aza-5alpha-Androstanes and the Tautomerism of 3-Oxo-4-Aza-5-Androstenes1. Heterocycles, 1998, Vol. 47, No 2, paginas 703-716. Pagina 703, esquema 1. *

Also Published As

Publication number Publication date
EP1116725A1 (en) 2001-07-18
DE60007716D1 (de) 2004-02-19
ATE257842T1 (de) 2004-01-15
US6509466B2 (en) 2003-01-21
WO2001002422A9 (es) 2001-04-05
US20010008895A1 (en) 2001-07-19
DE60007716T2 (de) 2004-12-09
WO2001002422A1 (es) 2001-01-11
HUP0103002A3 (en) 2002-09-30
CA2342864A1 (en) 2001-01-11
EP1116725B1 (en) 2004-01-14
ES2153789B1 (es) 2001-10-16
JP2003503507A (ja) 2003-01-28
HUP0103002A2 (hu) 2002-01-28

Similar Documents

Publication Publication Date Title
DE60309667D1 (de) Biphenylderivate und ihre verwendung als antiandrogene
HK1051683A1 (en) N-heterocyclic derivatives as nos inhibitors
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
DE60335717D1 (de) Azabicyclo-octan und nonan derivate mit ddp-iv hemmender wirkung
NO20003232D0 (no) Inhibering av RAF-kinase ved anvendelse av substituerte heterosykliske ureaforbindelser
RS107604A (en) Process for the manufacture of quinoline derivatives
HK1063641A1 (en) Novel polythiophene dispersions
SI1070056T1 (en) Phthalazinone pde iii/iv inhibitors
MX9704433A (es) Procedimiento para la preparacion de sildenafil.
DE60304059D1 (de) 3-(2-hydroxy-phenyl)-1h-pyrazol-4-carbonsäureamid derivate als hsp90 inhibitoren zur behandlung von krebs
AU3685601A (en) Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
ATE338047T1 (de) Stickstoffbasierte camptothecin-derivate
ES2153789A1 (es) Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides
HK1055304A1 (en) Tricyclic imidazopyridines
DE69417925T2 (de) 7-substituierte-4-aza-steroid-derivate als 5-alpha-reductase-hemmer
BR0215776A (pt) Processo para a preparação de derivados de pename a partir de derivados de cefame
AR011912A1 (es) PROCEDIMIENTO PARA LA PREPARACION DE COMPUESTOS DE 5-AMINO-1-ARIL-3-CIANOPIRAZOL, COMPUESTOS INTERMEDIARIOS DE APLICACIoN EN EL MISMO Y PROCESOS PARA PREPARAR DICHOS COMPUESTOS INTERMEDIARIOS
GB9923710D0 (en) Chemical compounds
WO2003018565A8 (en) Method for synthesizing oxazinones
EP1189909A4 (en) NOVEL ALUMINOSILOXANE COMPOUNDS, AND PROCESS FOR THEIR PREPARATION
AU2003233053A1 (en) Aqueous liquid compositions of reactive cyclodextrin derivatives and a finishing process using the said composition
AU4622800A (en) A stabilized isothiazolone composition and a method of stabilization of isothiazolone
WO2001025781A3 (de) Vorrichtung zur erzeugung von ein- oder mehrkomponenten-prüfgas organisch-chemischer stoffe
MX9700003A (es) Proceso para la reparacion de derivados de ??cido-clorometil-fenilglioxilico.
ES2184633A1 (es) Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010301

Kind code of ref document: A1

Effective date: 20010301

PC2A Transfer of patent
FD1A Patent lapsed

Effective date: 20100312